Radioimmunotherapy of human colon cancer xenografts with 131I-labeled anti-CEA monoclonal antibody

Bioconjugate Chemistry

Volumn 21, Issue 2, 2010, Pages 314-318

  Liu, Zhaofei ^a   Jin, Cunjing ^a   Yu, Zilin ^a   Zhang, Jing ^a   Liu, Yan ^a   Zhao, Huiyun ^a   Jia, Bing ^a   Wang, Fan ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; MAMMALS; TUMORS;

COLON CANCER; HUMAN COLON CANCER; HUMAN COLON CANCER CELLS; IN-VITRO; IN-VIVO; MICE MODELS; NUDE MICE; RADIOIMMUNOTHERAPY; THERAPEUTIC EFFICACY; VITRO AND IN VIVO;

MONOCLONAL ANTIBODIES;

CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY CL58 I 125; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY CL58 I 131; IODINE 125; IODINE 131; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; COLON CANCER; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG EFFICACY; EQUILIBRIUM CONSTANT; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; RADIOIMMUNOTHERAPY; TREATMENT RESPONSE; TUMOR VOLUME; XENOGRAFT;

ANIMALIA; MUS MUSCULUS;

EID: 77049087350     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc9003603     Document Type: Article

References (27)

1. Lynch, B. M., Youlden, D., Fritschi, L., Newman, B., Pakenham, K. I., Leggett, B., Owen, N., and Aitken, J. F. (2008) Selfreported information on the diagnosis of colorectal cancer was reliable but not necessarily valid. J. Clin. Epidemiol. 61, 498-504.
2. Wang, X. L., Yuan, Y., Zhang, S. Z., Cai, S. R., Huang, Y. Q., Jiang, Q., and Zheng, S. (2006) Clinical and genetic characteristics of Chinese hereditary nonpolyposis colorectal cancer families. World J. Gastroenterol. 12, 4074-4077
3. Lv, W., Zhang, C., and Hao, J. (2006) RNAi technology: a revolutionary tool for the colorectal cancer therapeutics. World J. Gastroenterol. 12, 4636-4639
4. Martenson, J. A., Jr., Willett, C. G., Sargent, D. J., Mailliard, J. A., Donohue, J. H., Gunderson, L. L., Thomas, C. R., Jr., Fisher, B., Benson, A. B., 3rd, Myerson, R., and Goldberg, R. M. (2004) Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130. J. Clin. Oncol. 22, 3277-3283
5. DeNardo, S. J., and Denardo, G. L. (2006) Targeted radionuclide therapy for solid tumors: an overview. Int. J. Radiat. Oncol. Biol. Phys. 66, S89-95.
6. Sharkey, R. M., and Goldenberg, D. M. (2005) Perspectives on cancer therapy with radiolabeled monoclonal antibodies. J. Nucl. Med. 46 (1), 115S-27S.
7. Jhanwar, Y. S., and Divgi, C. (2005) Current status of therapy of solid tumors. J. Nucl. Med. 46 (1), 141S-50S.
8. Vose, J. M. (2004) Bexxar: novel radioimmunotherapy for the treatment of low-grade and transformed low-grade non-Hodgkin's lymphoma. Oncologist 9, 160-172
9. Gordon, L. I., Witzig, T., Molina, A., Czuczman, M., Emmanouilides, C., Joyce, R., Vo, K., Theuer, C., Pohlman, B., Bartlett, N., Wiseman, G., Darif, M., and White, C. (2004) Yttrium 90- labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma. Clin. Lymphoma 5, 98-101.
10. Boswell, C. A., and Brechbiel, M. W. (2007) Development of radioimmunotherapeutic and diagnostic antibodies: an insideout view. Nucl. Med. Biol. 34, 757-778
11. Sharkey, R. M., and Goldenberg, D. M. (2008) Use of antibodies and immunoconjugates for the therapy of more accessible cancers. Adv. Drug Delivery Rev. 60, 1407-1420
12. Hammarstrom, S. (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Semin. Cancer Biol. 9, 67-81.
13. Goldenberg, D. M., Preston, D. F., Primus, F. J., and Hansen, H. J. (1974) Photoscan localization of GW-39 tumors in hamsters using radiolabeled anticarcinoembryonic antigen immunoglobulin G. Cancer Res. 34, 1-9.
14. Behr, T. M., Liersch, T., Greiner-Bechert, L., Griesinger, F., Behe, M., Markus, P. M., Gratz, S., Angerstein, C., Brittinger, G., Becker, H., Goldenberg, D. M., and Becker, W. (2002) Radioimmunotherapy of small-volume disease of metastatic colorectal cancer. Cancer 94, 1373-1381
15. Behr, T. M., Blumenthal, R. D., Memtsoudis, S., Sharkey, R. M., Gratz, S., Becker, W., and Goldenberg, D. M. (2000) Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments. Clin. Cancer Res. 6, 4900-4907
16. 131I-labetuzumab after salvage resection of colorectal liver metastases: comparison of outcome to a contemporaneous control group. Ann. Surg. Oncol. 14, 2577-2590
17. Yao, Y. F., Yang, Z., Li, Z. F., and Gu, J. (2007) Immunoscintigraphy of local recurrent rectal cancer with 99mTc-labeled anti-CEA monoclonal antibody CL58. World J. Gastroenterol. 13, 1841-1846
18. 125I-labeled carcinoembryonic antigen-specific monoclonal antibody submucosally. Dis. Colon Rectum 46, 1659-1666
19. Shao, W., Zhao, S., Liu, Z., Zhang, J., Ma, S., Sato, J. D., Zhang, P., Tong, M., Han, J., Wang, Y., Bai, D., Wang, F., and Sun, L. (2006) Inhibition of human tumor xenograft growth in nude mice by a conjugate of monoclonal antibody LA22 to epidermal growth factor receptor with anti-tumor antibiotics mitomycin C. Biochem. Biophys. Res. Commun. 349, 816-824
20. Liu, Z., Yu, Z., He, W., Ma, S., Sun, L., and Wang, F. (2009) In-vitro internalization and in-vivo tumor uptake of anti-EGFR monoclonal antibody LA22 in A549 lung cancer cells and animal model. Cancer Biother. Radiopharm. 24, 15-24.
21. Bertagnolli, M. M. (2005) Radioimmunotherapy for colorectal cancer. Clin. Cancer Res. 11, 4637-4638
22. Fujimori, K., Covell, D. G., Fletcher, J. E., and Weinstein, J. N. (1990) A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier. J. Nucl. Med. 31, 1191-1198
23. Adams, G. P., Schier, R., McCall, A. M., Simmons, H. H., Horak, E. M., Alpaugh, R. K., Marks, J. D., and Weiner, L. M. (2001) High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res. 61, 4750-4755
24. 3. Cancer Res. 66, 9673-9681
25. 3-targeted radioimmunotherapy of glioblastoma multiforme. Clin. Cancer Res. 14, 7330-7339
26. Schlom, J., Molinolo, A., Simpson, J. F., Siler, K., Roselli, M., Hinkle, G., Houchens, D. P., and Colcher, D. (1990) Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy. J. Natl. Cancer Inst. 82, 763-771
27. 131I anti-CEA radioimmunotherapy: effects on xenograft tumour growth and haematological toxicity in mice. Br. J. Cancer 99, 632-638.